Literature DB >> 12362575

The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants.

Herschel A Carpenter1, Albert J Czaja.   

Abstract

The diagnosis of autoimmune hepatitis requires a constellation of clinical, laboratory, and histologic features that exclude other conditions and support the syndrome. Interface hepatitis is the histologic hallmark of the disease, and it may be associated with panacinar hepatitis with or without bridging necrosis or multiacinar necrosis. The liver tissue examination at accession supports the diagnosis and assesses disease severity. It can also suggest the diagnosis in patients with atypical presentations, including those with an acute onset or cryptogenic disease. The liver tissue examination during therapy defines end points of treatment (remission) and evaluates unexpected outcomes (treatment failure, incomplete response). Manifestations of bile duct injury are incompatible with the classic diagnosis of autoimmune hepatitis, and they may be coincidental findings of no or uncertain clinical significance or weak expressions of a variant form. Histologic features of autoimmune hepatitis may intermix with those of PBC, PSC, and chronic hepatitis C infection, or they may occur in autoimmune cholangitis or cryptogenic chronic hepatitis. Conditions in which the histologic findings suggest the overlap of two disorders or are insufficient for designation as classic disease constitute the variant syndromes.

Entities:  

Mesh:

Year:  2002        PMID: 12362575     DOI: 10.1016/s1089-3261(02)00022-3

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  13 in total

Review 1.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

2.  Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.

Authors:  Ye H Oo; Stefan G Hubscher; David H Adams
Journal:  Hepatol Int       Date:  2010-05-19       Impact factor: 6.047

3.  Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis.

Authors:  Kazumichi Abe; Yukiko Kanno; Ken Okai; Fumiko Katsushima; Kyoko Monoe; Hironobu Saito; Atsushi Takahashi; Junko Yokokawa; Hiromasa Ohira
Journal:  World J Hepatol       Date:  2012-09-27

Review 4.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 5.  Diagnosis and management of the overlap syndromes of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Can J Gastroenterol       Date:  2013-07       Impact factor: 3.522

Review 6.  The overlap syndromes of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

7.  Autoimmune hepatitis in a North American Aboriginal/First Nations population.

Authors:  G Y Minuk; S Liu; K Kaita; S Wong; E Renner; J Rempel; J Uhanova
Journal:  Can J Gastroenterol       Date:  2008-10       Impact factor: 3.522

8.  Treatment of autoimmune liver disease: current and future therapeutic options.

Authors:  Palak J Trivedi; Gideon M Hirschfield
Journal:  Ther Adv Chronic Dis       Date:  2013-05       Impact factor: 5.091

Review 9.  Hepatic inflammation and progressive liver fibrosis in chronic liver disease.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Receptor-interacting protein kinase 3 mediates macrophage/monocyte activation in autoimmune hepatitis and regulates interleukin-6 production.

Authors:  Jun Zhang; Liping Guo; Mengjing Liu; Yang Jing; Simin Zhou; Hongxia Li; Yanni Li; Jingwen Zhao; Xingliang Zhao; Nathasha Karunaratna; Kui Jiang; Lu Zhou; Bangmao Wang
Journal:  United European Gastroenterol J       Date:  2018-01-25       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.